

Are we prescribing antibiotics wrong?

Outsourcing Clinical Trials Outside of the US

Regulators And Standards Groups Take Steps To Address Emerging Technologies In Biopharma

Two-dimensional liquid chromatography with multiple heart-cutting

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment





Latest White Papers
- Random
Featured News
Latest News
- Title
- Most Views
- Recently Added
- Ordering
- Random



Researchers at the Feinstein Institutes for Medical Research have developed a groundbreaking new ...

Obesity affects over a third of the global population and is a major risk factor for numerous ...

Piramal Pharma Limited a leading global pharmaceuticals and wellness company, in conjunction with ...

SFI Health™ is proud to celebrate the 25th anniversary of Equazen®, a globally recognized, ...



Latest Updates
Merck known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its primary endpoint of progression-free survival (PFS) for the ...
Merck known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its primary endpoint of progression-free survival (PFS) for the treatment of patients with platinum-resistant recurrent ovarian cancer whose tumors expressed PD-L1 ...
Gensco Laboratories LLC d/b/a Gensco Pharma, a leader in specialty pharmaceuticals, proudly announces the acquisition of the global rights and intellectual property for the first and only rizatriptan ...
Gensco Laboratories LLC d/b/a Gensco Pharma, a leader in specialty pharmaceuticals, proudly announces the acquisition of the global rights and intellectual property for the first and only rizatriptan Oral Dissolvable Film (ODF), which was co-developed under the trade names RizaFilm in the U.S. and ...
Private research nonprofit BrightFocus Foundation announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma. This ...
Private research nonprofit BrightFocus Foundation announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma. This includes $7.3 million to its Alzheimer’s Disease Research program, $3.8 million to its Macular ...
Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, NewSpring Healthcare, which invests in innovative ...
Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, NewSpring Healthcare, which invests in innovative companies in the lower-middle market that improve the delivery of healthcare or bend the cost curve ...
Rockwell Automation, Inc., the world's largest company dedicated to industrial automation and digital transformation, announced the launch of FactoryTalk® PharmaSuite® 12.00. The latest release of ...
Rockwell Automation, Inc., the world's largest company dedicated to industrial automation and digital transformation, announced the launch of FactoryTalk® PharmaSuite® 12.00. The latest release of its manufacturing execution system (MES) is designed to support the unique needs of regulated ...
OmniAb, Inc. the launch of the xPloration Partner Access Program, under which current OmniAb partners can purchase the xPloration instrument to significantly enhance their capabilities in antibody ...
OmniAb, Inc. the launch of the xPloration Partner Access Program, under which current OmniAb partners can purchase the xPloration instrument to significantly enhance their capabilities in antibody discovery and development. xPloration is OmniAb’s proprietary, innovative, high-throughput single ...